ZACKS
Search documents
AMC Entertainment (AMC) Laps the Stock Market: Here's Why
ZACKS· 2026-02-17 23:46
Company Overview - AMC Entertainment's stock increased by 1.63% to $1.25, outperforming the S&P 500's daily gain of 0.1% [1] - Over the past month, AMC's shares have declined by 23.6%, while the Consumer Discretionary sector and S&P 500 lost 2.88% and 1.43%, respectively [1] Upcoming Earnings - AMC Entertainment is set to release its earnings report on February 24, 2026, with an expected loss of -$0.16 per share, indicating a year-over-year growth of 11.11% [2] - The consensus estimate for revenue is projected at $1.28 billion, reflecting a decrease of 2.37% from the previous year [2] Full Year Estimates - For the full year, analysts expect AMC to report earnings of -$1.17 per share and revenue of $4.83 billion, representing changes of +8.59% and +4.09% from the previous year, respectively [3] Analyst Estimates - Recent changes in analyst estimates for AMC suggest a positive outlook on the company's business operations and profit generation capabilities [4] - The Zacks Rank system, which incorporates these estimate changes, currently rates AMC as 3 (Hold) [6] Industry Context - AMC operates within the Leisure and Recreation Services industry, which is part of the Consumer Discretionary sector [7] - The current Zacks Industry Rank for this sector is 190, placing it in the bottom 23% of over 250 industries [7]
Genco Shipping & Trading (GNK) Q4 Earnings and Revenues Surpass Estimates
ZACKS· 2026-02-17 23:40
Genco Shipping & Trading (GNK) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +11.24%. A quarter ago, it was expected that this transporter of drybulk cargo would post a loss of $0.01 per share when it actually produced a loss of $0.01, delivering no surprise.Over the last four quart ...
Rogers Corp. (ROG) Q4 Earnings and Revenues Beat Estimates
ZACKS· 2026-02-17 23:40
Rogers Corp. (ROG) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +48.33%. A quarter ago, it was expected that this specialty materials company would post earnings of $0.7 per share when it actually produced earnings of $0.9, delivering a surprise of +28.57%.Over the last four quarter ...
Centerspace (CSR) Tops Q4 FFO Estimates
ZACKS· 2026-02-17 23:40
分组1 - Centerspace (CSR) reported quarterly funds from operations (FFO) of $1.25 per share, exceeding the Zacks Consensus Estimate of $1.21 per share, and showing an increase from $1.21 per share a year ago, resulting in an FFO surprise of +3.31% [1] - The company posted revenues of $66.62 million for the quarter ended December 2025, which was 4.14% below the Zacks Consensus Estimate, but slightly higher than the year-ago revenues of $66.41 million [2] - Centerspace has surpassed consensus FFO estimates two times over the last four quarters and topped consensus revenue estimates three times during the same period [2] 分组2 - The stock has underperformed the market, losing about 4.7% since the beginning of the year, compared to a decline of 0.1% for the S&P 500 [3] - The current consensus FFO estimate for the coming quarter is $1.21 on revenues of $68.8 million, and for the current fiscal year, it is $4.81 on revenues of $276.8 million [7] - The Zacks Industry Rank for REIT and Equity Trust - Residential is in the bottom 38% of over 250 Zacks industries, indicating potential challenges for stock performance [8]
Toll Brothers (TOL) Q1 Earnings and Revenues Beat Estimates
ZACKS· 2026-02-17 23:40
Core Insights - Toll Brothers (TOL) reported quarterly earnings of $2.19 per share, exceeding the Zacks Consensus Estimate of $2.05 per share, and up from $1.75 per share a year ago, representing an earnings surprise of +6.66% [1] - The company achieved revenues of $2.15 billion for the quarter ended January 2026, surpassing the Zacks Consensus Estimate by 16.42%, compared to $1.86 billion in the same quarter last year [2] - Toll Brothers shares have increased by approximately 22.9% since the beginning of the year, while the S&P 500 has declined by 0.1% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $2.94 on revenues of $2.52 billion, and for the current fiscal year, it is $12.69 on revenues of $10.4 billion [7] - The estimate revisions trend for Toll Brothers was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Building Products - Home Builders industry, to which Toll Brothers belongs, is currently ranked in the bottom 2% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]
AtriCure (ATRC) Tops Q4 Earnings and Revenue Estimates
ZACKS· 2026-02-17 23:36
分组1 - AtriCure reported quarterly earnings of $0.06 per share, exceeding the Zacks Consensus Estimate of a loss of $0.02 per share, and showing improvement from a loss of $0.08 per share a year ago, resulting in an earnings surprise of +400.00% [1] - The company achieved revenues of $140.5 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.01% and increasing from $124.28 million year-over-year [2] - AtriCure has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] 分组2 - The stock has underperformed the market, losing about 17.5% since the beginning of the year, compared to a decline of 0.1% in the S&P 500 [3] - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at -$0.09 for the coming quarter and $0.02 for the current fiscal year [7] - The Medical - Products industry, to which AtriCure belongs, is currently ranked in the bottom 40% of Zacks industries, which may impact stock performance [8]
Bel Fuse (BELFB) Beats Q4 Earnings and Revenue Estimates
ZACKS· 2026-02-17 23:36
Core Insights - Bel Fuse (BELFB) reported quarterly earnings of $1.98 per share, exceeding the Zacks Consensus Estimate of $1.68 per share, and showing a significant improvement from a loss of $0.14 per share a year ago, resulting in an earnings surprise of +17.86% [1] - The company achieved revenues of $175.94 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.49% and increasing from $149.86 million year-over-year [2] - Bel Fuse has consistently outperformed consensus EPS and revenue estimates over the last four quarters, indicating strong operational performance [2] Earnings Outlook - The future performance of Bel Fuse's stock will largely depend on management's commentary during the earnings call and the sustainability of the recent earnings surprise [3][4] - The current consensus EPS estimate for the upcoming quarter is $1.56 on revenues of $162.47 million, while for the current fiscal year, the estimate is $7.35 on revenues of $714.97 million [7] Industry Context - Bel Fuse operates within the Zacks Electronics - Miscellaneous Products industry, which is currently ranked in the top 20% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - The correlation between near-term stock movements and earnings estimate revisions is strong, indicating that positive revisions could lead to further stock price appreciation [5][6]
Huntsman (HUN) Reports Q4 Loss, Beats Revenue Estimates
ZACKS· 2026-02-17 23:30
Huntsman (HUN) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -25.68%. A quarter ago, it was expected that this chemical company would post a loss of $0.13 per share when it actually produced a loss of $0.03, delivering a surprise of +76.92%.Over the last four quarters, the company has sur ...
Cadence (CDNS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2026-02-17 23:30
Cadence Design Systems (CDNS) reported $1.44 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 6.2%. EPS of $1.99 for the same period compares to $1.88 a year ago.The reported revenue represents a surprise of +1.12% over the Zacks Consensus Estimate of $1.42 billion. With the consensus EPS estimate being $1.90, the EPS surprise was +4.57%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations t ...
Medifast (MED) Reports Q4 Loss, Beats Revenue Estimates
ZACKS· 2026-02-17 23:30
分组1 - Medifast reported a quarterly loss of $0.55 per share, better than the Zacks Consensus Estimate of a loss of $0.76, representing an earnings surprise of +27.63% [1] - The company posted revenues of $75.1 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 6.05%, but down from $119 million year-over-year [2] - Medifast has surpassed consensus EPS estimates two times and revenue estimates three times over the last four quarters [2] 分组2 - The stock's immediate price movement will depend on management's commentary during the earnings call and future earnings expectations [3][4] - Medifast shares have increased by about 0.8% since the beginning of the year, while the S&P 500 has declined by 0.1% [3] - The current consensus EPS estimate for the coming quarter is -$0.12 on revenues of $67.12 million, and -$0.57 on revenues of $228.38 million for the current fiscal year [7] 分组3 - The Zacks Industry Rank indicates that the Food - Miscellaneous sector is in the bottom 16% of over 250 Zacks industries, which may impact stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that tracking these revisions can be beneficial for investors [5][6] - Medifast currently holds a Zacks Rank 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6]